1 year return (CAGR)
154.52%
Immunome Inc Exchange (NASDAQ, USD)
IMNM
22.34
+1.10 (+4.59%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
49.65%
5 year return (CAGR)
3.79%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.85B
Price/Sales
-
Ent value
2.67B
Price/Book
5.42
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-14.31%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 24.63 |
| Daily high | 25.25 |
| Daily low | 24.19 |
| Daily Volume | 1.15M |
| All-time high | 43.24 |
| 1y analyst estimate | 36.31 |
| Beta | 2.12 |
| EPS (TTM) | -2.25 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Mar 2026 |
Downside potential
Loading...
Downside potential data
| IMNM | S&P500 | |
| Current price drop from All-time high | -48.33% | -1.38% |
| Highest price drop | -94.89% | -56.47% |
| Date of highest drop | 30 Dec 2022 | 9 Mar 2009 |
| Avg drop from high | -66.19% | -10.68% |
| Avg time to new high | 107 days | 12 days |
| Max time to new high | 1400 days | 1805 days |
News
